Bain Capital Life Sciences Investors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,132,397
| Closed | -$16.6M | – | 27 |
|
|
2024
Q1 | $16.6M | Sell |
1,132,397
-690,486
| -38% | -$10.2M | 1.34% | 16 |
|
|
2023
Q4 | $18.8M | Hold |
1,822,883
| – | – | 1.8% | 15 |
|
|
2023
Q3 | $14.3M | Hold |
1,822,883
| – | – | 1.6% | 15 |
|
|
2023
Q2 | $18.2M | Hold |
1,822,883
| – | – | 1.88% | 18 |
|
|
2023
Q1 | $16.2M | Hold |
1,822,883
| – | – | 2.02% | 17 |
|
|
2022
Q4 | $20M | Hold |
1,822,883
| – | – | 2.24% | 15 |
|
|
2022
Q3 | $23.8M | Hold |
1,822,883
| – | – | 2.84% | 13 |
|
|
2022
Q2 | $23.1M | Buy |
1,822,883
+538,570
| +42% | +$6.82M | 2.71% | 12 |
|
|
2022
Q1 | $18M | Hold |
1,284,313
| – | – | 1.75% | 15 |
|
|
2021
Q4 | $37.2M | Sell |
1,284,313
-1
| -0% | -$29 | 2.95% | 12 |
|
|
2021
Q3 | $38.5M | Hold |
1,284,314
| – | – | 2.39% | 12 |
|
|
2021
Q2 | $34.1M | Hold |
1,284,314
| – | – | 2.23% | 10 |
|
|
2021
Q1 | $39.9M | Hold |
1,284,314
| – | – | 2.26% | 12 |
|
|
2020
Q4 | $42.2M | Hold |
1,284,314
| – | – | 2.65% | 11 |
|
|
2020
Q3 | $44.8M | Buy |
+1,284,314
| New | +$44.8M | 4.18% | 8 |
|